GenFleet Therapeutics (Shanghai) (HKSE:02595) Cash Flow for Dividends: HK$0.0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02595 GenFleet Therapeutics (Shanghai) Inc HKSE:02595
10 GF Score
Price HK$27.60
! 3 Warning Signs
View Full Analysis

What is GenFleet Therapeutics (Shanghai) Cash Flow for Dividends?

GenFleet Therapeutics (Shanghai) HKSE:02595 +1.85% 10 Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus rates HKSE:02595 with a GF Score™ of 10/100. The stock has 3 warning signs investors should review.

GenFleet Therapeutics (Shanghai)'s cash flow for dividends for the six months ended in Dec. 2025 was HK$0.0 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0.0 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

GenFleet Therapeutics (Shanghai) Cash Flow for Dividends Related Terms

GenFleet Therapeutics (Shanghai) Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for GenFleet Therapeutics (Shanghai)'s Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GenFleet Therapeutics (Shanghai) Cash Flow for Dividends Chart

GenFleet Therapeutics (Shanghai) Annual Data
Trend Dec23 Dec24 Dec25
Cash Flow for Dividends
0.00 0.00 0.00

GenFleet Therapeutics (Shanghai) Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends 0.00 0.00 0.00 0.00 0.00
HKSE:02595
10GF Score
GenFleet Therapeutics (Shanghai) Inc HKSE:02595
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GenFleet Therapeutics (Shanghai) Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of HK$0.0 Mil mean?
GenFleet Therapeutics (Shanghai) (HKSE:02595) has a Cash Flow for Dividends of HK$0.0 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for GenFleet Therapeutics (Shanghai) and its competitors.
Is GenFleet Therapeutics (Shanghai)'s Cash Flow for Dividends too high?
GenFleet Therapeutics (Shanghai)'s current Cash Flow for Dividends is HK$0.0 Mil. Overall, GenFleet Therapeutics (Shanghai) has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does GenFleet Therapeutics (Shanghai)'s Cash Flow for Dividends compare to VRTX and REGN?
GenFleet Therapeutics (Shanghai)'s Cash Flow for Dividends of HK$0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for GenFleet Therapeutics (Shanghai) and its competitors. GenFleet Therapeutics (Shanghai)'s current Cash Flow for Dividends is HK$0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GenFleet Therapeutics (Shanghai) stock overvalued right now?
GenFleet Therapeutics (Shanghai) (HKSE:02595) has a current Cash Flow for Dividends of HK$0.0 Mil. The current Cash Flow for Dividends is HK$0.0 Mil. GenFleet Therapeutics (Shanghai)'s overall GF Score™ is 10/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For GenFleet Therapeutics (Shanghai) (HKSE:02595), the current Cash Flow for Dividends is HK$0.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

GenFleet Therapeutics (Shanghai) Business Description

Other Exchanges Y3L:Germany
Address 1206 Zhangjiang Road, Floors 2nd, 3rd, 4th, and 5th, Building 8, Shanghai Pilot Free Trade Zone, Shanghai, CHN, 201203
GenFleet Therapeutics (Shanghai) Inc Company is a clinical-stage biotechnology company. The Company and its subsidiaries are principally engaged in the research, development and commercialisation of pharmaceutical products. The Group is engaged in biopharmaceutical research and development, which is regarded as a single reportable segment.
10GF Score

Get the complete analysis for HKSE:02595

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$27.60
Price